The commercial track record with transcatheter mitral valve repair, approved for patients at high risk for surgery, compares favorably with pre-approval reports, according to findings from a U.S. registry presented at the American College of Cardiology's 64th Annual Scientific Session.
from The Medical News http://ift.tt/1ADEGA4
from The Medical News http://ift.tt/1ADEGA4
No comments:
Post a Comment